Kaken Pharmaceutical , Ltd. Common Stock

Kaken Pharmaceutical , Ltd. (KKPCF) currently reports a common stock of $24B as of September 2026. That compares with $24B in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Kaken Pharmaceutical , Ltd.'s common stock history and peer comparisons.

Kaken Pharmaceutical , Ltd.'s common stock was unchanged from $24B to $24B — essentially flat versus a year earlier (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kaken Pharmaceutical , Ltd. reported $24B in common stock as of September 2026. That compares with $24B in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $24B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kaken Pharmaceutical , Ltd., and consider following KKPCF for alerts when major investors trade the stock.